Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
2.030
-0.060 (-2.87%)
At close: Nov 1, 2024, 4:00 PM
2.050
+0.020 (0.99%)
After-hours: Nov 1, 2024, 7:19 PM EDT
Longeveron Employees
As of December 31, 2023, Longeveron had 24 total employees, including 23 full-time and 1 part-time employees. The number of employees increased by 3 or 14.29% compared to the previous year.
Employees
24
Change (1Y)
3
Growth (1Y)
14.29%
Revenue / Employee
$51,208
Profits / Employee
-$1,162,667
Market Cap
29.15M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 24 | 3 | 14.29% |
Dec 31, 2022 | 21 | 1 | 5.00% |
Dec 31, 2021 | 20 | 8 | 66.67% |
Dec 31, 2020 | 12 | -4 | -25.00% |
Dec 31, 2019 | 16 | - | - |
Related Stocks
Company Name | Employees |
---|---|
FibroGen | 486 |
DarioHealth | 294 |
Celularity | 120 |
SAB Biotherapeutics | 57 |
Femasys | 34 |
Lipocine | 17 |
NeuroOne Medical Technologies | 16 |
BriaCell Therapeutics | 16 |
LGVN News
- 3 days ago - Longeveron® Presents Lomecel-B™ Data for Alzheimer's Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24) - GlobeNewsWire
- 5 days ago - Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons' Society (CHSS) 51st Annual Meeting - GlobeNewsWire
- 18 days ago - Longeveron® Lomecel-B™ Data in Alzheimer's Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24) - GlobeNewsWire
- 23 days ago - Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons' Society (CHSS) 51st Annual Meeting - GlobeNewsWire
- 25 days ago - Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day - GlobeNewsWire
- 4 weeks ago - Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 5 weeks ago - Longeveron to Attend Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa - GlobeNewsWire
- 2 months ago - Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire